A Nevada court has issued a temporary restraining order against prediction market platform Polymarket, blocking it from offering event contracts to state residents. The ruling marks a significant early victory for state gaming regulators amid a national debate over who should oversee these fast-growing markets.
The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.
Glaukos Corporation secures a significant FDA nod allowing repeated administration of its sustained-release iDose TR implant, broadening treatment options for patients with glaucoma and potentially reshaping long-term care paradigms.
Exelixis shares have delivered impressive multi-year returns, but recent price weakness has investors questioning if the rally has run its course. A deep dive into valuation models suggests the stock may still be significantly undervalued, presenting a potential opportunity amidst market uncertainty.
A Nevada court has temporarily blocked the prediction market platform Polymarket, siding with state regulators who argue its event contracts constitute illegal gambling. The ruling intensifies a global regulatory crackdown that threatens the core business model of an emerging financial sector.
Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.
Amidst shifting economic currents in Asia, a class of smaller companies—often overlooked as 'penny stocks'—is attracting attention for their distinct financial profiles and niche market positions. We analyze three such firms with market capitalizations below US$200 million.
Amidst a cautiously optimistic Asian market, companies where executives and directors hold significant stakes are drawing investor attention. We examine three high-conviction plays in semiconductors, 3D printing, and biotech where insider ownership aligns with explosive growth forecasts.
IDEAYA Biosciences shares have retreated from recent highs, presenting investors with a dilemma. While long-term performance remains strong, its premium valuation and significant net losses raise questions about whether the current price already reflects its promising pipeline.
Laura Fernández, former chief of staff to President Rodrigo Chaves, holds a commanding lead and could secure an outright victory, promising to double down on the incumbent's hardline security agenda.
The Portuguese government has launched a massive financial aid package, combining loans and direct support, to accelerate recovery from the deadly Storm Kristin which left a trail of destruction across the country last week.
Prominent Venezuelan human rights defender Javier Tarazona has been released after over four years in detention on charges widely condemned as politically motivated, as the government announces a new amnesty law and the U.S. re-engages diplomatically.
Voters head to the polls in Costa Rica, with the ruling right-wing populist party aiming to secure a decisive mandate and a legislative supermajority to tackle record violence and political gridlock.
Nomura's digital asset arm, Laser Digital, reports quarterly losses leading to reduced crypto exposure, even as it aggressively pursues a US banking charter and global expansion, highlighting a dual-track strategy of short-term risk management and long-term infrastructure build-out.
BeOne Medicines (NasdaqGS: ONC) has significantly expanded its strategic partnership with systems biology firm InSysBio. The deepened collaboration aims to leverage advanced mechanistic modeling to de-risk clinical trial design, with a particular focus on optimizing dosing and preempting safety challenges like cytokine release syndrome in oncology studies.
As Merck prepares to release its fourth-quarter results, investors are watching to see if the pharmaceutical leader can maintain its track record of exceeding expectations amid a slowing growth outlook.
As Pfizer prepares to report its fourth-quarter results, investors are weighing the company's strategic pivot beyond its COVID-19 portfolio against a backdrop of expected revenue declines. The report may set the tone for the broader pharmaceutical sector.
Homeland Security Secretary Kristi Noem asserted her department is 'always learning' while defending its actions, as veteran official Tom Homan arrives in Minneapolis to oversee ICE operations following violent clashes and mounting political pressure.
A coordinated two-week operation between ICE and multiple West Virginia law enforcement agencies has resulted in the arrest of more than 650 individuals for immigration violations, including some with criminal histories.
The Hong Kong Monetary Authority has detailed its enhanced oversight framework for key retail payment systems, designating networks like Visa, Mastercard, and UnionPay for direct supervision to ensure security and stability in the city's rapidly digitizing economy.
